Molecular cloning of a DNA-end-binding protein (Ku antigen) recognized by autoantibodies and its application.

自身抗体识别的DNA末端结合蛋白(Ku抗原)的分子克隆及其应用。

基本信息

  • 批准号:
    62570296
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1987
  • 资助国家:
    日本
  • 起止时间:
    1987 至 1988
  • 项目状态:
    已结题

项目摘要

Anti-ku autoantibodies in patients with PSS-PM overlap syndrome recognize a 70kD/80kD protein heterodimer which binds to ends of dsDNA. In this project, we isolated and characterized cDNA clones that encode the Ku autoantigen, and intended their clinical application.In the first year, a human hepatoma cell cDNA library inserted into the EcoRl site of lambda gtll phages were screened with an anti-Ku serum to identify plaques expressing Ku epitopes. Three positive clones (K14, K68 and K71) were isolated and deomnstrated to express fusion proteins recognized by anti-Ku antibodies. In the second year, Okayama-berg cDNA library was screened by using a previously isolated cDNA encoding the partial 80kD sequence (K71) as a probe for colony hybridization. The clone Ku80-6 that contained the longest cDNA insert (3.4kb, ldentical with the larger mRNA from two mRNAs hybridized by K71) was isolated, and its nucleotide sequence was determined by Sanger's dideoxy method. The Ku80-6 cDNA contained a … More single long open reading frame encoding 732 amino acids (Mr=82,713) followed by 1082 bases of 3'-non-coding region and a poly(A) tail. The sequence of the Ku80-6 was compared with previously described sequences using the computer search, but no significant homology was found either in DNA (GenBank) or protein (NBRF) data bank. In Southern blot, the Ku80-6 hybridized with 4-5 DNA bands from human leukocyte DNA digested with various restriction enzymes. It was noted that RFLP was seen in the 3.4kb-HindIII fragment and likely to associate with SLE patients who had anti-ULRNP antibodies. Using purified fusion proteins expressing from K68(70kD) and K71(80kD) clones, we developed ELISA to detect anti-Ku antibodies. When sera from various collagen diseases were screened by this assay, anti-Ku antibodies were mostly detected in patients with overlap syndrome, consisted with the result of a conventional immunodiffusion assay.Our cDNA encoding the Ku antigenic proteins will be a powerful tool to study not only the structure and function of the Ku antoantigen but also pathogenetic mechanisms of autoimmune diseases. Less
PSS-PM重叠综合征患者的抗ku自身抗体识别与dsDNA末端结合的70 kD/80 kD蛋白异源二聚体。本项目分离并鉴定了编码Ku自身抗原的cDNA克隆,并计划将其用于临床应用。第一年,用抗Ku血清筛选插入λ gtll噬菌体EcoRl位点的人肝癌细胞cDNA文库,以鉴定表达Ku表位的噬斑。分离到3个阳性克隆(K14、K68和K71),经鉴定,它们表达了抗Ku抗体识别的融合蛋白。第二年,以已分离的80 kD部分序列(K71)为探针,对Okayama-berg cDNA文库进行了筛选。克隆Ku 80 -6含有最长的cDNA插入片段(3.4kb,与K71杂交的两个mRNA中较大的mRNA相同),用桑格双脱氧法测定其核苷酸序列。Ku 80 -6 cDNA含有一个 ...更多信息 单个长开放阅读框编码732个氨基酸(Mr= 82,713),随后是1082个碱基的3 '-非编码区和一个poly(A)尾。将Ku 80 -6的序列与已报道的序列进行了计算机检索,但在DNA(GenBank)和蛋白质(NBRF)数据库中均未发现明显的同源性。在Southern杂交中,Ku 80 -6与经各种限制性内切酶消化的人白细胞DNA的4-5条DNA带杂交。结果表明,3.4kb-HindIII片段存在RFLP,且可能与SLE患者抗ULRNP抗体有关。用纯化的K68(70 kD)和K71(80 kD)融合蛋白建立了检测抗Ku抗体的ELISA方法。用该方法筛选各种胶原病患者血清时,大多数重叠综合征患者血清中均检出抗Ku抗体,与常规免疫扩散法的结果一致,我们获得的编码Ku抗原蛋白的cDNA将为研究Ku自身抗原的结构和功能以及自身免疫性疾病的发病机制提供有力的工具。少

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
三森経世: 日本臨床.
三森常世:日本临床。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
三森経世: 最新医学. 42. 2419-2430 (1987)
三森常世:最新医学。42。2419-2430(1987)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Mimori et al: "Molecular cloning of the human autoantigen Ku (p70/p80)" Arthritis Rheum. 31. 13 (1988)
T. Mimori 等人:“人类自身抗原 Ku (p70/p80) 的分子克隆”大黄关节炎。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Mimori: Arthritis Rheum. 31. S13 (1988)
T.Mimori:关节炎大黄。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
三森経世: 日本臨床. 46. 790-797 (1988)
三森常世:日本临床杂志 46. 790-797 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIMORI Tsuneyo其他文献

MIMORI Tsuneyo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIMORI Tsuneyo', 18)}}的其他基金

Study for pathological significance of autoantibodies and establishment of therapy in myositis-associated intractable acute interstitial pneumonia
肌炎相关难治性急性间质性肺炎自身抗体的病理意义研究及治疗方案的建立
  • 批准号:
    25293222
  • 财政年份:
    2013
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of pathogenicity and development of novel therapy byinflammation-regulating proteins in systemic autoimmune diseases
系统性自身免疫性疾病的致病性分析及炎症调节蛋白新疗法的开发
  • 批准号:
    22390201
  • 财政年份:
    2010
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical and pathophysiological significance of novel identified anti-IFIH1/MDA5 autoantibody in amyopathic dermatomyositis
新型抗 IFIH1/MDA5 自身抗体在无肌病性皮肌炎中的临床和病理生理学意义
  • 批准号:
    22659185
  • 财政年份:
    2010
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of pathophysiology and novel therapeutic approach for rheumatic diseases by arthritis-regulated proteins
关节炎调节蛋白的病理生理学分析和风湿性疾病的新治疗方法
  • 批准号:
    18390290
  • 财政年份:
    2006
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of pathogenesis and control of arthritis in rheumatoid arthritis by calpain-calpastatin system
钙蛋白酶-钙蛋白酶抑制素系统分析类风湿性关节炎发病机制及防治
  • 批准号:
    16390287
  • 财政年份:
    2004
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Significance of anti-calpastatin antibodies in rheumatic diseases and their effect on osteoclast
抗钙蛋白酶抑制剂抗体在风湿性疾病中的意义及其对破骨细胞的影响
  • 批准号:
    12670437
  • 财政年份:
    2000
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical and pathogenic significance and its therapeutic application of anti-calpastatin antibodies in rheumatoid arthritis
抗钙蛋白酶抑制剂抗体在类风湿性关节炎中的临床、致病意义及其治疗应用
  • 批准号:
    09670492
  • 财政年份:
    1997
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical and pathological significance of autoantibodies to calpastatin in rheumatoid arthritis
类风湿性关节炎中钙蛋白酶抑制剂自身抗体的临床和病理意义
  • 批准号:
    07670540
  • 财政年份:
    1995
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Function of the DNA-terminal binding protein regognized by anti-Ku antibodies and its etiologic significance in collagen disease
抗Ku抗体识别的DNA末端结合蛋白的功能及其在胶原病中的病因学意义
  • 批准号:
    04670395
  • 财政年份:
    1992
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Cloning of cDNA encoding the DNA-terminal binding protein (Ku)
编码 DNA 末端结合蛋白 (Ku) 的 cDNA 的克隆
  • 批准号:
    01570369
  • 财政年份:
    1989
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
桥粒芯糖蛋白 3 嵌合自身抗体受体 T 细胞 (DSG3-CAART) 对粘膜寻常型天疱疮的免疫调节作用
  • 批准号:
    10679911
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Elucidating the immunology of autoantibody formation and function in COVID-19
阐明 COVID-19 中自身抗体形成和功能的免疫学
  • 批准号:
    10639707
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Analysis of abnormal post-translational modifications that promote autoantibody production using high-precision mass spectrometry
使用高精度质谱分析促进自身抗体产生的异常翻译后修饰
  • 批准号:
    23K07915
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical application based on the molecular mechanism of autoantibody production in autoimmunity
基于自身抗体产生的分子机制在自身免疫中的临床应用
  • 批准号:
    23K18361
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Dynamic prediction of type 1 diabetes risk and autoantibody status by a joint model of longitudinal and multistate models
通过纵向和多状态模型的联合模型动态预测1型糖尿病风险和自身抗体状态
  • 批准号:
    10630731
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Novel therapeutic strategies targeting autoantibody-producing RP105-negative B cells by t-SNE method
通过 t-SNE 方法针对产生自身抗体的 RP105 阴性 B 细胞的新治疗策略
  • 批准号:
    23K07910
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Extracellular vesicle and autoantibody production
细胞外囊泡和自身抗体的产生
  • 批准号:
    23K15265
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of mechanism of autoantibody production in pemphigus in conjunction with information from single cell analysis
结合单细胞分析信息阐明天疱疮自身抗体产生的机制
  • 批准号:
    22K08416
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Influence of HTLV-1 for autoantibody production system and Th subset
HTLV-1对自身抗体产生系统和Th亚群的影响
  • 批准号:
    22K08552
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Multi-Platform Homogeneous Multiplexed Autoantibody Assay Based on Liquid Micropiston-Enhanced Time-Resolved Forster Resonance Energy Transfer
基于液体微活塞增强时间分辨福斯特共振能量转移的多平台同质多重自身抗体测定
  • 批准号:
    10576777
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了